RIG 200
RIG 200 is an S-nitrosothiol nitric oxide (NO) donor. RIG 200 releases NO through decomposition, activating guanylate cyclase (sGCM) in vascular smooth muscle cells, increasing cGMP levels, and leading to vasodilation. RIG 200 significantly inhibits Collagen (HY-NP003)-induced platelet aggregation in platelet-rich plasma (PRP). RIG 200 may be used in research on antithrombus.
For research use only. We do not sell to patients.
- CAS No.: 202656-49-3
- Formula: C21H31N3O12S
- Molecular Weight:549.55
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
RIG 200 (4-100 μM) inhibits platelet aggregation induced by Collagen with an IC₅₀ of 0.8 μM in platelet-rich plasma (PRP) but is impossible to inhibit platelet aggregation in whole blood (WB)[1].
RIG 200 (10 μM) significantly increases the cGMP level of platelets in PRP[1].
RIG 200 (0.01-10 μM, 30 min) continuously inhibits the contraction effect of isolated vascular rings, and its dilating effect can significantly persist after elution[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 202656-49-3
-
Molecular Weight 549.55
-
Formula C21H31N3O12S
-
SMILES
CC(O[C@@H]1[C@H]([C@@H](O[C@H](COC(C)=O)[C@H]1OC(C)=O)OC(C)=O)NC([C@H](NC(C)=O)C(C)(C)SN=O)=O)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. Megson IL, et al. Inhibition of human platelet aggregation by a novel S-nitrosothiol is abolished by haemoglobin and red blood cells in vitro: implications for anti-thrombotic therapy. Br J Pharmacol. 2000 Dec;131(7):1391-8. [Content Brief]
[2]. Sogo N, et al. S-nitrosothiols cause prolonged, nitric oxide-mediated relaxation in human saphenous vein and internal mammary artery: therapeutic potential in bypass surgery. Br J Pharmacol. 2000 Nov;131(6):1236-44. [Content Brief]
[3]. Sogo N, et al. A novel S-nitrosothiol (RIG200) causes prolonged relaxation in dorsal hand veins with damaged endothelium. Clin Pharmacol Ther. 2000 Jul;68(1):75-81. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
RIG 200 Related Classifications
HY-107000 Related Classifications
Powered by Bioz